Population pharmacokinetics of the novel anticancer agent KRN7000 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Galactosylceramides

abstract

  • The pharmacokinetic behavior of KRN7000 in the clinical trial could be described by a three-compartment model. Hence, KRN7000 demonstrates linear pharmacokinetics over the investigated dose range. The pharmacokinetics of KRN7000 are not influenced by patient demographic or pathophysiological characteristics.

publication date

  • April 6, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s00280-001-0413-3

PubMed ID

  • 11914907

Additional Document Info

start page

  • 287

end page

  • 93

volume

  • 49

number

  • 4